Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CLBS

Caladrius Biosciences (CLBS) Stock Price, News & Analysis

Caladrius Biosciences logo

About Caladrius Biosciences Stock (NASDAQ:CLBS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.43
$8.38
52-Week Range
N/A
Volume
466,373 shs
Average Volume
522,308 shs
Market Capitalization
$26.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CLBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Caladrius Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CLBS Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
CLBS Caladrius Biosciences, Inc.
See More Headlines

CLBS Stock Analysis - Frequently Asked Questions

Caladrius Biosciences, Inc. (NASDAQ:CLBS) announced its quarterly earnings results on Thursday, November, 4th. The biotechnology company reported ($1.80) EPS for the quarter, beating analysts' consensus estimates of ($1.95) by $0.15.

Caladrius Biosciences's stock reverse split on Thursday, September 15th 2022.The 1-15 reverse split was announced on Thursday, September 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Caladrius Biosciences investors own include Meta Platforms (META), Brainstorm Cell Therapeutics (BCLI), HubSpot (HUBS), Alphabet (GOOG), NVIDIA (NVDA), OPKO Health (OPK) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
11/04/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Miscellaneous Health & Allied Services
Sub-Industry
N/A
Current Symbol
NASDAQ:CLBS
CIK
320017
Employees
27
Year Founded
2006

Profitability

EPS (Trailing Twelve Months)
($0.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-27.24%
Return on Assets
-26.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
22.33
Quick Ratio
22.33

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.54 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
60,583,000
Free Float
59,250,000
Market Cap
$26.05 million
Optionable
Optionable
Beta
0.91

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CLBS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners